+100%-

Geoff’s Narration

The Blog

 

Ron Davis

Ron Davis brings researchers together every year to probe deeper into ME/CFS. Among the attendees this year: Akiko Iwasaki, David Systrom, Carmen Scheibenbogen, Jarred Younger, Liisa Selin, Chris Ponting, Andrew Grimson, Paul Hwang, Chris Armstrong, Rob Wust, Kenny DeMeirleir, Bob Naviaux, Bhupresh Prusty.

Have you ever tried to drink out of a firehose?

Me neither. Until last week.

That’s when I attended Ron Davis’s annual Working Group meeting. That’s where a roaring firehose of ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome) science, research results, data and charts and graphs and concepts and theories and researcher’s names — along with their many titles and university affiliations — came rushing at me.

For four solid days (September 3-6, 2024), from 11 am to 4 pm ET, I tried to drink from this fire hose, intellectually speaking.

Maybe I took in 10% of it…? Okay, more like 5.

I spent most of those four days in bed, where you’ll often find me. I watched the invite-only Zoom meeting on my laptop, usually cloaked (camera off). Yet I asked questions and was an active participant in the meeting’s chat. I typed about how my (or others’) experiences as a patient related to the research of 100 or so speakers. With so many attending, the chat was ever-bubbling, ever-popping with new posts. Blink, and you could miss ten attendees asking probing questions of the speaker or offering comments on the scientific findings displayed on their slides.

I’m no scientist; I’m an advocate. So it’s not surprising I did not grasp much of what was relayed by this pantheon of powerhouse PhDs. My advocacy work over the decades has focused on supporting patients, writing, organizing panels, working with elected officials and more. Since the pandemic, I’ve also been dedicated to Long COVID (LC) and the newly-coined broader community of “infection-associated chronic conditions and illnesses” (IACCIs).

That said, I do work with two Massachusetts research labs as a patient rep. In our meetings, I listen with delight to their delight about just-analyzed blood samples. Then I ask, “Can you please re-state that in layman’s terms?” I mean, I can tell from their excitement that it’s all good. But really, who can understand that impossible-to-understand scientific lingo?

Well, impossible-to-understand scientific lingo reigned at Ron Davis’s meeting. Every half hour or so, some new person presented data on ME/CFS and LC in what (to me) sounded like ancient Greek. Plus, it was all filtered through my cognitive dysfunction. As a result, even if I were allowed to share details about the meeting (I’m not), could I now summarize for you the presentations? Relay groundbreaking news? Tell you about promising treatments? Nope. No. Still no.

So why did I even attend this gathering? And why write this debrief for you?

I’m here to offer hope. I want you to know what I now know only because I was able to attend this closed-door meeting: There are dozens of PhDs who want to help us, who are actively working to help us. That’s their job. And they take their jobs seriously.

At the start of every day, Ashley Haugan, Ron Davis’s daughter, and the nimble meeting organizer, opened with a welcome and any housekeeping items. At the end of every whirlwind day, because this affair is a family affair, Janet Dafoe, Ron Davis’s wife, and a noted patient advocate, shared patients’ feedback that she’d gotten on her Twitter/X account. The feedback was full of gratitude for the researchers.

A slide from the meeting

A slide from the meeting posted by Janet Dafoe

The two meeting moderators were upbeat and super smart. They were able to synthesize what each speaker had just said in their presentation and relate it to the larger context of the meeting. They also deftly read aloud and framed for the room the questions that had come in via the chat for each speaker.

Though I could never summarize for you all that I’d heard, still the four-day firehose experience was amazing. Most remarkable was the last half day. Ron, frustrated by not getting the freewheeling, deep-probing, pulling-it-all-together discussion he was hoping for, forced a new module onto the group. Ron asked the Zoom room to discuss (paraphrasing): What will it take to figure out this disease? How can we integrate our theories, which are now siloed, and instead work together? How do we decide which theories can best explain ME/CFS symptoms, especially PEM?

Ron put deep thinker Rob Phair in charge of this group conversation focused on the big “what’s, why’s and how’s.” To direct us, Rob asked the room:

  • Is ME/CFS viral, reactivation viral, or truly post-viral?
  • Is ME/CFS primarily an inflammatory disease?
  • What is the nature of immune dysfunction in ME? (Exhaustion? Subversion by pathogen? Autoantibodies?)
  • What is the source of ME/CFS chronicity?
  • Is mitochondrial dysfunction the final common pathway of ME? (Or is mitochondrial dysfunction primary?)
  • What is the mechanism of PEM?

This Rob Phair facilitated freewheeling, big picture brainstorm session was focused and limited, because only the presenters of the last four days were given the floor. It was also incredibly stimulating. Some researchers shared their overall theories about what is going on with this disease, i.e. why we are all languishing in our beds.

Firehose

It may have been like drinking out of firehose but for Rivka the outcome was clear: committed researchers working hard to solve ME/CFS.

An additional exercise was added on near the end of the meeting: Any researcher who spoke was then asked to name another researcher from the conference with whom they’d like to talk or collaborate. That generated some enthusiastic “Let’s connect; here’s my email address” type of interactions. It was great to witness this knocking down of silos. In fact, the Massachusetts researchers I personally work with made valuable connections with two other researchers that, if the relationships build, could clearly advance the field.

In closing: I spent last week hanging out with a bunch of smart-cookie researchers whose careers are focused on explaining, and ending, our suffering. Take heart, friends, we are not alone. I have hope — and I want to share some of that with you.

Check out Jarred Younger’s Update from the Working Group Meeting.

 

 

BIO: Rivka Solomon (Twitter/X: RivkaTweets) is an ME/LC/IACCI advocate based in Massachusetts, and a member of MassME. She is also a patient representative working with two collaborating labs: the Selin Lab, at UMass Chan Medical School, Worcester, MA, with Liisa Selin, MD, PhD, and Anna Gil, PhD, and HiFiBiO Therapeutics, Cambridge, MA, with Roshan Kumar, PhD. Funded in part by the Patient-Led Research Fund, these labs are investigating ME/LC immune dysregulation and profiling the immune repertoires of T cells at a single-cell level. The Selin Lab is also working towards a potential biomarker for ME/LC.

Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News

Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities. 

Thank you for signing up!

Pin It on Pinterest

Share This